Cambridge, MA, United States of America

Jennifer Downing

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations of Jennifer Downing

Introduction

Jennifer Downing is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 4 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents, Jennifer has developed heterobicyclic amides as inhibitors of CD38. This invention relates to heterobicyclic amides and related compounds that serve as inhibitors of CD38, which are useful in the treatment of cancer. Her innovative approach in this area showcases her commitment to advancing medical science.

Career Highlights

Throughout her career, Jennifer has worked with notable companies such as Boehringer Ingelheim International GmbH and Ribon Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jennifer has collaborated with esteemed colleagues, including Laurie B. Schenkel and Kevin Wayne Kuntz. These partnerships have played a crucial role in her research and development efforts.

Conclusion

Jennifer Downing's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight her innovative spirit and dedication to improving healthcare. Her patents and collaborations reflect her significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…